Effect of Cyclophosphamide Pretreatment on Defective Delayed-Type Hypersensitivity in Autoimmune-Prone MRL Mice

Harue Okuyama(Hokkaido University), Kenichi Yamamoto(The University of Osaka), Takashi Matsunaga(Shiga University of Medical Science), Seiichi Kobayashi, Yoshinori Kawaguchi(Daiichi Sankyo (United States)), Y. Hashimoto(Nihon University)

International Archives of Allergy and Applied Immunology

August 5, 2009

10.1159/000234723

Cited by 1

Related Papers

A cross-population atlas of genetic associations for 220 human phenotypes

|Nature Genetics|2021|2.4k

Validation of A New Prognostic Staging System for Hepatocellular Carcinoma: the Jis Score Compared With the Clip Score

|Hepatology|2004|359

Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study

|The Lancet Oncology|2023|237

Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis

|Journal of Gastroenterology|2009|205

Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers

|Clinical Gastroenterology and Hepatology|2006|127